Gary H. Gibbons, M.D. - May 16, 2013
As you probably know by now, we have recently received greater clarity from the Congress and Office of Management and Budget (OMB) on the fiscal year (FY) 2013 budget, and the NHLBI funding and operating guidelines for the current fiscal year are now posted here: http://www.nhlbi.nih.gov/research/funding/general/current-operating-guidelines.
Our approach to fiscal stewardship of the NHLBI's allocation of the public's resources involves a mission-driven investment strategy that is guided by several key enduring principles:
- Value and support investigator-initiated fundamental discovery science.
- Maintain a balanced, cross-disciplinary portfolio (basic, translational, clinical, population science).
- Support implementation science that empowers patients and enables partners to improve the health of the nation.
- Train and nurture a diverse biomedical workforce.
- Value the health of all communities; elucidate and eliminate health inequities in the U.S. and around the globe.
The fiscal austerity mandated by our appropriation was implemented based on these enduring principles that prioritize investments in investigator-initiated R01 awards, new/early stage investigators, and trainees. Accordingly, the NHLBI FY 2013 payline for R01 awards will exceed the FY 2012 payline with an increase to the 11th percentile from the current 6th percentile. This approach should yield an increase in the number of R01 awards funded in FY 2013 relative to FY 2012. Similarly, despite the overall cut in the budget, our prioritization strategy will strive to restore paylines to other mechanisms related to trainees and early-stage investigators toward those of FY 2012.
Given the NHLBI's mission to serve the public interest, I want to express my gratitude to you for your contribution to the collective shared sacrifice necessitated by this budget reduction.
For more information about NIH fiscal operations, please refer to the NIH notice: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-13-064.html.